If you are using Wegovy, you may want to know how long the medicine remains in your body, especially if you are having side effects that bother you
New research shows that those who stop using tend to regain weight, but not all the way to their pre-treatment level
External resources Journal of the American Heart Association: GLP-1 RAs and risk of VTE meta-analysis Endocrine Journal: Comprehensive safety analysis of semaglutide (SUSTAIN/PIONEER meta-analysis) American Society of Hematology: GLP-1 RA and VTE propensity-matched study In case I do not see you, good afternoon, good evening, and good night
In these trials, MOUNJARO was studied as monotherapy (SURPASS-1)
But with so many programs to choose from, it can be hard to narrow down which one is best
GI side effects and dose relationship Gastrointestinal symptoms are the most common adverse events reported with retatrutide, and they follow a clear dose-dependent pattern